Renal effects of amlodipine

Area of Science:

• Nephrology
• Pharmacology
• Cardiology

Background:

• Hypertension is a major risk factor for chronic kidney disease.
• Dihydropyridine calcium channel blockers and ACE inhibitors are used to manage hypertension and protect renal function.
• Understanding the comparative effects of these drug classes on renal function is crucial for patient management.

Purpose of the Study:

• To evaluate the effects of amlodipine on blood pressure and renal function in spontaneously hypertensive rats (SHR) and hypertensive patients with renal impairment.
• To compare the renoprotective effects of amlodipine with an angiotensin-converting enzyme (ACE) inhibitor, enalapril.
• To investigate the mechanisms of action of amlodipine in renal protection.

Main Methods:

• Administration of amlodipine (2 mg/kg/day) to nephrectomized, salt-loaded SHR and comparison with enalapril.
• Assessment of blood pressure, urinary protein excretion, and serum creatinine in rats.
• Evaluation of amlodipine's effects on blood pressure and renal function in 39 hypertensive patients with renal impairment over 8-10 weeks.

Main Results:

• Amlodipine attenuated increases in blood pressure, urinary protein, and serum creatinine in SHR, with effects comparable to enalapril.
• Amlodipine did not significantly dilate the efferent arteriole in a rat kidney model, suggesting a different mechanism than enalapril.
• In hypertensive patients, amlodipine (2.5-5 mg/day) significantly reduced blood pressure in 80% of subjects, with minimal changes in blood urea nitrogen and serum creatinine.

Conclusions:

• Amlodipine demonstrates significant renoprotective effects in hypertensive rats, comparable to enalapril.
• The mechanism of renal protection by amlodipine appears to differ from that of enalapril.
• Amlodipine is effective in reducing blood pressure in hypertensive patients with renal impairment with a favorable renal function profile.